ArticleNature genetics2011
GATA2 mutations lead to MDS and AML.
Article in Nature genetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 34 citations in OpenAlex.
- [Alert in germline mutation predisposed to myeloid neoplasm: myelodysplastic syndromes accompanied with GATA2 deficeincy syndrome].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2021Article
- Mycobacterial diseases in patients with inborn errors of immunity.Current opinion in immunology · 2021Review
- Inherited GATA2 Deficiency Is Dominant by Haploinsufficiency and Displays Incomplete Clinical Penetrance.Journal of clinical immunology · 2021Article
- Review
- Inhibition of GATA2 restrains cell proliferation and enhances apoptosis and chemotherapy mediated apoptosis in human GATA2 overexpressing AML cells.Scientific reports · 2019Article
- Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia.BMC medical genomics · 2019Article
- Germline GATA2 Mutation and Bone Marrow Failure.Hematology/oncology clinics of North America · 2018Review
- Fanconi Anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML.Oncotarget · 2018Article
- Role of RUNX1 in hematological malignancies.Blood · 2017Review
- The emerging role of GATA transcription factors in development and disease.Expert reviews in molecular medicine · 2016Review
- Somatic mutational landscape of AML with inv(16) or t(8;21) identifies patterns of clonal evolution in relapse leukemia.Leukemia · 2016Article
- Genomic Profile of Chronic Lymphocytic Leukemia in Korea Identified by Targeted Sequencing.PloS one · 2016Article
- Haematopoietic and immune defects associated with GATA2 mutation.British journal of haematology · 2015Review
- Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations.Cancer medicine · 2015Review
- Heritable GATA2 mutations associated with familial AML-MDS: a case report and review of literature.Journal of hematology & oncology · 2014Review
- Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations.Annals of the New York Academy of Sciences · 2014Review
- Review
- Atherosclerosis and transit of HDL through the lymphatic vasculature.Current atherosclerosis reports · 2013Review
- Mutations in the VEGFR3 signaling pathway explain 36% of familial lymphedema.Molecular syndromology · 2013Article
- GATA2 zinc finger 2 mutation found in acute myeloid leukemia impairs myeloid differentiation.Leukemia research reports · 2013Article
Corrections and comments
- Comment on
- Comment on
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.